🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/08/2001 | 65,84 | 67,03 | 65,27 | 66,78 | +1,58% | 2,68% | 5.027.466 |
| 15/08/2001 | 66,79 | 67,53 | 65,52 | 65,74 | -1,57% | 3,00% | 5.011.955 |
| 14/08/2001 | 66,60 | 66,81 | 66,22 | 66,79 | +0,50% | 0,89% | 3.714.322 |
| 13/08/2001 | 66,30 | 66,75 | 66,13 | 66,46 | +0,90% | 0,94% | 3.732.871 |
| 10/08/2001 | 64,68 | 66,26 | 64,63 | 65,87 | +1,78% | 2,52% | 4.492.462 |
| 09/08/2001 | 64,46 | 64,86 | 64,04 | 64,71 | -0,04% | 1,27% | 5.173.033 |
| 08/08/2001 | 64,67 | 65,65 | 64,60 | 64,74 | -0,92% | 1,62% | 4.371.942 |
| 07/08/2001 | 64,46 | 65,37 | 64,27 | 65,34 | +1,57% | 1,70% | 3.043.182 |
| 06/08/2001 | 64,99 | 65,39 | 64,16 | 64,33 | -1,01% | 1,89% | 3.391.118 |
| 03/08/2001 | 64,17 | 65,49 | 64,06 | 64,99 | +0,47% | 2,23% | 3.553.349 |
| 02/08/2001 | 64,92 | 65,28 | 64,57 | 64,69 | -0,29% | 1,09% | 3.563.514 |
| 01/08/2001 | 64,42 | 65,36 | 64,19 | 64,88 | +0,01% | 1,82% | 4.879.907 |
| 31/07/2001 | 63,41 | 65,84 | 63,34 | 64,87 | +2,61% | 3,94% | 6.950.965 |
| 30/07/2001 | 62,16 | 63,59 | 61,83 | 63,22 | +1,70% | 2,82% | 4.328.869 |
| 27/07/2001 | 62,40 | 62,82 | 61,83 | 62,16 | +0,59% | 1,59% | 4.086.257 |
| 26/07/2001 | 62,02 | 62,12 | 61,34 | 61,79 | -0,35% | 1,26% | 5.757.922 |
| 25/07/2001 | 62,48 | 62,81 | 61,83 | 62,01 | +0,09% | 1,56% | 5.525.266 |
| 24/07/2001 | 62,69 | 62,83 | 61,64 | 61,96 | -1,17% | 1,90% | 5.280.558 |
| 23/07/2001 | 63,41 | 63,93 | 62,69 | 62,69 | -1,10% | 1,96% | 4.185.293 |
| 20/07/2001 | 63,91 | 64,47 | 63,22 | 63,39 | -1,29% | 1,96% | 6.835.161 |
| 19/07/2001 | 64,46 | 64,69 | 63,46 | 64,22 | -0,37% | 1,89% | 9.108.273 |
| 18/07/2001 | 62,01 | 64,46 | 61,92 | 64,46 | +4,76% | 4,09% | 11.479.792 |
| 17/07/2001 | 60,07 | 61,93 | 60,07 | 61,53 | +2,38% | 3,10% | 8.083.329 |
| 16/07/2001 | 59,21 | 60,11 | 58,68 | 60,10 | +2,41% | 2,40% | 7.019.190 |
| 13/07/2001 | 58,44 | 59,59 | 58,30 | 58,68 | +0,82% | 2,20% | 9.735.291 |
| 12/07/2001 | 58,78 | 58,78 | 57,59 | 58,21 | -2,18% | 2,03% | 11.811.903 |
| 11/07/2001 | 60,24 | 60,54 | 58,72 | 59,50 | -2,13% | 3,03% | 9.164.865 |
| 10/07/2001 | 61,53 | 61,75 | 60,73 | 60,80 | -1,36% | 1,66% | 5.754.044 |
| 09/07/2001 | 61,07 | 61,83 | 60,85 | 61,64 | +1,83% | 1,61% | 7.066.140 |
| 06/07/2001 | 61,20 | 61,48 | 60,52 | 60,53 | -1,09% | 1,56% | 4.250.374 |